Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Management System Market – Forecasts from 2019 to 2024” report has been added to ResearchAndMarkets.com’s offering.…
@alvogenpr subsidiary in Taiwan, Lotus Pharmaceuticals today announced capital and business collaboration agreements with Fuji Pharma in Japan, as Fuji has acquired a 2.0% stake in Lotus for approximately US$20 million (or NT$ 617 million, JPY 2.2 billion). Lotus has also acquired 3.9% stake in Fuji for an equal sum.
Verona Pharma as Non-Executive Director
The new Oasmia board, led by Jörgen Olsson who was elected as the Chairman, independent Board member and former CEO of Hoist Finance, will review the business and proceedings of Oasmia in several aspects.
Minneapolis, Chicago and Cleveland lead the pack in investment, while the number of Midwest companies receiving funding increases 20% CLEVELAND–(BUSINESS…
BOSTON–(BUSINESS WIRE)–Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI)…
WATERTOWN, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CEO?src=hash" target="_blank"gt;#CEOlt;/agt;–FORMA Therapeutics announced today the appointment of Frank D. Lee as Chief Executive Officer, starting on…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that interim…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (NYSE American: AGE), a biotechnology company focused on innovative therapeutics for human aging, announced today…
SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is an innovative biotechnology company focusing on research and production of cannabinoids. The company utilizes its…